PIONEER POWER SOLUTIONS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PIONEER POWER SOLUTIONS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.63M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $22.88M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $11.12M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $25.88M | Jul 26, 2024 |
| FY2022 | Dec 31, 2021 | $18.31M | Apr 11, 2023 |
| FY2021 | Dec 31, 2020 | $19.49M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $20.58M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $20.13M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $114.39M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $99.63M | Apr 2, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.63M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $22.88M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $11.12M | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | $11.45M | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $12.28M | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $9.56M | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | $25.88M | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | $6.37M | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | $4.83M | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | $6.34M | Jul 26, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.43M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $5.51M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $2.23M | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | $3.70M | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $3.88M | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $2.83M | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | $2.83M | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | $2.17M | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | ($1.23M) | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | ($888.0K) | Jul 26, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.00M) | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $31.86M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($1.90M) | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | $1.01M | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $848.0K | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $742.0K | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | ($5.42M) | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | $2.0K | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | ($3.83M) | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | ($2.55M) | Jul 26, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.60M) | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | ($5.25M) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($7.04M) | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | $940.0K | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $789.0K | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $675.0K | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | ($5.81M) | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | ($131.0K) | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | ($3.81M) | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | ($2.63M) | Jul 26, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $875.0K | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $1.05M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $885.0K | Apr 15, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.15M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $9.71M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $8.38M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $8.64M | Jul 26, 2024 |
| FY2022 | Dec 31, 2021 | $5.26M | Apr 11, 2023 |
| FY2021 | Dec 31, 2020 | $5.17M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $12.92M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $11.02M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $21.16M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $16.74M | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.82M) | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | ($6.21M) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($3.90M) | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | ($228.0K) | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $366.0K | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $1.53M | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | ($5.77M) | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | ($3.94M) | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | ($1.62M) | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | $2.09M | Jul 26, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.68M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $3.76M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $2.50M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.51M | Jul 26, 2024 |
| FY2022 | Dec 31, 2021 | $237.0K | Apr 11, 2023 |
| FY2020 | Dec 31, 2019 | $153.0K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $589.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.45M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $668.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $1.05M | Mar 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.46M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $65.95M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $33.02M | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | $35.70M | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $31.00M | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $34.61M | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | $35.39M | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | $27.60M | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | $30.20M | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | $32.92M | Jul 26, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.14M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $30.52M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $18.80M | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | $17.21M | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $13.31M | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $18.59M | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | $20.24M | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | $13.54M | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | $16.30M | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | $15.84M | Jul 26, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.32M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $35.43M | Apr 8, 2026 |
| FY2025 | Dec 31, 2023 | $14.22M | Apr 8, 2026 |
| FY2023 | Sep 30, 2023 | $18.49M | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | $17.69M | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | $16.02M | Jul 26, 2024 |
| FY2024 | Dec 31, 2022 | $15.15M | Apr 15, 2025 |
| FY2023 | Sep 30, 2022 | $14.05M | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | $13.91M | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | $17.08M | Jul 26, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2018 | $2.97M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $8.53M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $8.53M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $10.07M | Mar 29, 2017 |
| FY2015 | Dec 31, 2014 | $9.61M | Mar 31, 2016 |
| FY2015 | Dec 31, 2013 | $8.00M | Mar 31, 2016 |
| FY2013 | Dec 31, 2012 | $6.89M | Mar 14, 2014 |
| FY2013 | Dec 31, 2011 | $6.86M | Mar 14, 2014 |
| FY2012 | Dec 31, 2010 | $5.53M | Apr 1, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.00M) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($19.63M) | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | ($15.13M) | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | ($16.14M) | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | ($16.99M) | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | ($17.73M) | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | ($18.69M) | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | ($18.69M) | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | ($14.86M) | Jul 26, 2024 |
| FY2022 | Dec 31, 2021 | ($12.31M) | Apr 11, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $41.62M | Apr 15, 2025 |
| FY2023 | Dec 31, 2023 | $3.58M | Jul 26, 2024 |
| FY2020 | Dec 31, 2020 | $7.57M | Mar 30, 2021 |
| FY2020 | Dec 31, 2019 | $8.21M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $211.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $218.0K | Mar 29, 2019 |
| FY2018 | Dec 31, 2016 | $246.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2015 | $648.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2014 | $3.83M | Mar 29, 2017 |
| FY2015 | Dec 31, 2013 | $425.0K | Mar 31, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2020 | $1.41M | Mar 31, 2022 |
| FY2014 | Dec 31, 2014 | $9.54M | Apr 2, 2015 |
| FY2014 | Dec 31, 2013 | $7.21M | Apr 2, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | 0 | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jul 26, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Sep 30, 2023 | 0 | Jul 26, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Jul 26, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Jul 26, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Jul 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Jul 26, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Jul 26, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jul 26, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.10M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | 11.12M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | 9.93M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 9.64M | Jul 26, 2024 |
| FY2022 | Dec 31, 2021 | 9.64M | Apr 11, 2023 |
| FY2021 | Dec 31, 2020 | 8.73M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 8.73M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | 8.73M | Mar 30, 2020 |
| FY2019 | Dec 31, 2017 | 8.73M | Mar 30, 2020 |
| FY2017 | Dec 31, 2016 | 8.70M | Apr 2, 2018 |